Immunotherapy for Neuroblastoma

Apr 6, 2019 by in NEUROLOGY Comments Off on Immunotherapy for Neuroblastoma

Abstract Current therapeutic approaches for high-risk neuroblastoma include dose-intensive chemotherapy, surgical and radiotherapeutic interventions that are associated with long- and short-term toxicities. Immunotherapy utilizes mechanisms of action that are not…

read more

Current Pharmacotherapy for Neuroblastoma

Apr 6, 2019 by in NEUROLOGY Comments Off on Current Pharmacotherapy for Neuroblastoma

Abstract Neuroblastoma is, at once, a common and a frequently deadly cancer seen almost exclusively in children. The prognosis for patients with neuroblastoma is best in those whose tumor burden…

read more

Role of Stemness Factors in Neuroblastoma: Neuroblastoma Stem Cells, Tumor Microenvironment, and Chemoresistance

Apr 6, 2019 by in NEUROLOGY Comments Off on Role of Stemness Factors in Neuroblastoma: Neuroblastoma Stem Cells, Tumor Microenvironment, and Chemoresistance

Abstract The cancer stem cell paradigm is the idea that subpopulations of cancer cells exist within a tumor that are capable of self-renewal, multipotency, proliferation, and tumor maintenance. This subpopulation…

read more

Energy Metabolism and Metabolic Targeting of Neuroblastoma

Apr 6, 2019 by in NEUROLOGY Comments Off on Energy Metabolism and Metabolic Targeting of Neuroblastoma

Abstract Energy metabolism refers to all the reactions involved in generating adenosine triphosphate (ATP) from nutrients, including both aerobic respiration (oxygen present), anaerobic respiration (fermentation) as well as fatty acid…

read more

Neuroblastoma Pathology and Classification for Precision Prognosis and Therapy Stratification

Apr 6, 2019 by in NEUROLOGY Comments Off on Neuroblastoma Pathology and Classification for Precision Prognosis and Therapy Stratification

Abstract Tumors in neuroblastoma group offer one of the best models for investigating the biologically significant relationship between their genetic/molecular properties and morphologic manifestations. Over the past decades, histopathological analysis…

read more

GD2-Targeted Immunotherapy of Neuroblastoma

Apr 6, 2019 by in NEUROLOGY Comments Off on GD2-Targeted Immunotherapy of Neuroblastoma

Abstract Disialoganglioside GD2 is highly expressed on neuroectodermal tumors and sarcomas, but only weakly expressed on limited normal tissues. It has been identified as a marker for a subset of…

read more

Transcranial Doppler Ultrasonography

Apr 6, 2019 by in NEUROLOGY Comments Off on Transcranial Doppler Ultrasonography

Abstract Monitoring the cerebral blood flow (CBF) is critical in patients with known neurological disease as well as in patients at risk of neurological damage in the perioperative period. Transcranial…

read more
Get Clinical Tree app for offline access